MedPath

COMPARISON OF THE TREATMENTOUTCOMES ON GUM DISEASE WITH THE USE OF PERIOGENâ?¢ AND BLOOD COMPONENT

Not Applicable
Completed
Registration Number
CTRI/2019/02/017391
Lead Sponsor
SAIRA SABA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

Inclusion Criteria

1.Systemically healthy subjects.

2.Patients 18-40 years of age.

3.Bilateral Millerâ??s class I and II gingival recession.

4.Patients with >=1mm of width of keratinized gingiva.

5.Patients with a thick gingival biotype.

6.Presence of good oral hygiene maintenance.

7.Non smokers

Exclusion Criteria

Exclusion Criteria:

1.Presence of dehiscence or fenestration.

2.Malposed teeth.

3.Root caries.

4.History of any periodontal surgery in same area in the past 6 months.

5.Pregnant or lactating women.

6.Patients on medications.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prior to surgery an acrylic stent will be fabricated on the patients cast for standardization of the measurements to be assessed and following clinical parameters will be assessed in millimetres using UNC-15 Probe: <br/ ><br>1.Gingival recession depth. <br/ ><br>2.Gingival recession width. <br/ ><br>3.Probing depth. <br/ ><br>4.Clinical attachment level. <br/ ><br>5.Keratinized gingival width. <br/ ><br>Timepoint: AT BASELINE <br/ ><br>3 MONTHS POST SURGERY <br/ ><br>6 MONTHS POST SURGERY
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NIL <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath